FDA Import Refusal SCS-3522221-0/10002/1 — Glaxosmithkline Argentina S.A.
The FDA refused shipment SCS-3522221-0/10002/1 from Glaxosmithkline Argentina S.A. (Argentina) on August 27, 2025. The refused product falls under Drugs and Biologics — SODIUM BICARBONATE (REPLENISHER). Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- August 27, 2025
- Country
- Argentina
- Product Category
- Drugs and Biologics
- Product Code
- 65RBC18 SODIUM BICARBONATE (REPLENISHER)
- Charges
- 118,3280,75